Building the future of Life Sciences

In the pharmaceutical sector, sub-contracting is supporting the development of the “4.0” production chain, whose ideal and technological value grows hand in hand with the ability to innovate and start wide-ranging collaborations. All this will be at Pharmintech (Bologna, 10 - 12 April 2019), the exhibition dedicated to the pharmaceutical, nutritional, biotechnology and personal care industries.

In the coming years, the main companies of the Life Science industry will have to adopt new models of strategic collaboration with their suppliers and partners who, in turn, will increasingly rely on technological innovation and advanced production capacity.
Thanks to the adoption of advanced technologies (artificial intelligence, robotics and cognitive automation, cloud computing), manufacturers will be asked to increase production efficiency and optimize management, containing costs and focusing on quality control and a turnkey service, reducing time-to-market as much as possible.

 
Sub-contracting in particular, in Italy represents a true excellence: € 1.9 billion the value of production (source Prometeia for Farmindustria), which represents 24% of the EU total (€ 7.9 billion) and underlines the distance with Germany (1.7 billion) and France ( 1,5), with investments in research and development equal to 12% of turnover.
This sector will continue to contribute to the growth of the Life Science sector thanks to new cutting edge technologies and know-how.
It is expected that the focus on patient centrality, risk-based monitoring, the digitization of clinical trials, adaptive trials and analytics will decisively orientate the propensity to productive outsourcing.
 
In Europe, third-party production - or contract development and manufacturing organizations (CDMO) - stands out for the high level of hi-tech investments, for highly qualified human resources, the strong propensity to export, the added value and the competitiveness.
This is an advanced sector that, in a short time, from the first steps in the 90s, has made its way into the global market in the wake of changes in global pharmaceutical demand, thanks to the ability to efficiently manage ever higher grade quality productions. The greatest growth momentum was registered precisely for the most innovative products: injectables and high-activity biological productions.

From 2010 to today, 80% of contractors’ investment spending has been allocated to new production lines or modernization of existing ones. Common goal: strengthen the production facilities to respond with speed, service, flexibility, quality and reliability to the demands of an increasingly demanding market.
Automated supply chain management, remote control of production processes, use of software to plan production and reconfiguration of plants - with feasibility checks in 3D environment (virtual factory) - are the elements that have introduced large-scale organizational methods that respond to Industry 4.0 requirements.

Therefore, the Life Science sector is closely related to the excellence and competence of the technological partners, and Pharmintech Exhibition 2019 stands as the natural meeting point of this industrial chain: the event presents the best of process, packaging, laboratory instrumentation, packaging, components, digital and automation solutions applied to the sector - from IoT to data governance.
The partnership between pharmaceutical, biotechnological, nutritional and cosmetic companies on the one hand, and between contractors and companies operating in the field of advanced technologies, on the other, is defining a “revolutionary” Life Science 4.0.

In fact, a technological renewal is underway that enables an effective and completely different response from the past to autoimmune diseases, intolerances or tumors, also arising from the increase in life expectancy, which require personalized treatments and drugs.
Today, technology not only makes it possible to make these pharmaceuticals, but to also produce them in a sustainable way: a challenge for the Life Science sector, called upon to make a further evolution to which Pharmintech will contribute actively.

Seminars and round tables organized during the Bologna event will exhaustively deepen the cross-cutting themes, while the state-of-the-art technological solutions in the field of processing, packaging, sterile rooms, management of production facilities and the integrated supply chain will be brought to the attention of the visitors from the more than 300 exhibitors expected, bearing witness to the excellence at international level of the supplier industry.

Calendared in synergy with Cosmofarma (12-14 April 2019), Pharmintech Exhibition will contribute to realize a complete and diversified exhibition proposal, giving life to the “Bologna Health Week”, a real meeting point for the management, professional operators and technicians of the supply chain of the entire Life Science system.